Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
Johanna Mercier sold 28,000 shares of GILD on 15 August at $118.97 per share, worth a total of $3.3M. They now own 117,168 GILD shares, or a 20% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
